Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin C pseudogene 8 (ELOCP8)
- Target
- ELOCP8
- Molecular classification
- Other (Pseudogene)
01
Overview
Elongin C pseudogene 8 (ELOCP8) is a human pseudogene associated with the locus for elongin C but does not encode a protein or have direct biological activity. It is listed in gene databases as a pseudogene, meaning it is a DNA sequence with high similarity to the active ELOC gene but is not transcribed into a functional product. There is no evidence for therapeutic targeting, biomarker utility, or drug interactions for ELOCP8. All known functional and disease associations relate to the true ELOC gene, not its pseudogenes.
- Other names
- TCEB1P8transcription elongation factor B (SIII), polypeptide 1 pseudogene 8transcription elongation factor B subunit 1 pseudogene 8ELOCP8
Beyond the preview
Go deeper on Elongin C pseudogene 8 (ELOCP8).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elongin C pseudogene 8 (ELOCP8).